13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$388.71B
+4.3% on the quarter before
Positions
437
31 new · 20 sold out
Top 10
26.4%
of the value
Est. gain
+$17.21B
on stocks held all quarter
Est. return
+5.1%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 42% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$4.05BNew · 0.0% → 1.0%+11,385,326 shares
- General Electric Co~$2.87BAdded · 0.5% → 1.3%+30,047,717 shares
- Public Storage~$1.65BNew · 0.0% → 0.4%+5,466,587 shares
- Alphabet~$1.56BAdded · 1.7% → 2.3%+15,013,907 shares
- Union Pac Corp~$1.33BAdded · 0.3% → 0.6%+6,595,704 shares
- America Movil Sab De Cv~$1.04BNew · 0.0% → 0.3%+49,346,313 shares
- Welltower Inc~$796.0MAdded · 0.1% → 0.3%+11,102,865 shares
- Constellation Brands Inc~$760.7MAdded · 0.2% → 0.4%+3,367,364 shares
- Exxon Mobil Corp~$723.2MAdded · 0.2% → 0.4%+6,594,579 shares
- Bristol-Myers Squibb Co~$602.9MAdded · 1.0% → 1.1%+8,700,136 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$3.34BSold out · 0.9% → 0.0%−10,237,758 shares
- Broadcom~$1.69BCut · 4.5% → 4.6%−2,638,069 shares
- Cvs Health Corp~$1.56BCut · 0.7% → 0.1%−20,957,031 shares
- Chubb Limited~$1.01BCut · 1.2% → 0.7%−5,204,825 shares
- Conocophillips~$996.8MCut · 1.1% → 0.6%−10,047,291 shares
- Meta~$871.8MCut · 1.4% → 2.1%−4,113,462 shares
- Netflix~$866.9MCut · 1.2% → 1.1%−2,509,319 shares
- Honeywell Technologies~$853.6MCut · 0.6% → 0.3%−4,468,022 shares
- Horizon Therapeutics Pub L~$840.7MCut · 0.3% → 0.0%−7,702,586 shares
- America Movil Sab De Cv~$833.9MSold out · 0.2% → 0.0%−45,780,428 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +1.4% · price +20.2% | 6.3% | $24.51B | +$4.06B | ||||||||
| BroadcomCOM · shares −8.7% · price +14.7% | 4.6% | $17.70B | +$2.27B | ||||||||
| Philip Morris Intl IncCOM · shares +4.6% · price −3.9% | 2.6% | $10.23B | −$398.9M | ||||||||
| AlphabetCAP STK CL C · shares +21% · price +17.2% | 2.3% | $8.91B | +$1.08B | ||||||||
| MetaCL A · shares −9.8% · price +76.1% | 2.1% | $8.03B | +$3.47B | ||||||||
| Comcast Corp NewCL A · shares −7.7% · price +8.4% | 1.8% | $7.11B | +$550.1M | ||||||||
| Unitedhealth Group IncCOM · shares −10% · price −10.9% | 1.8% | $7.00B | −$853.1M | ||||||||
| Abbvie IncCOM · shares −9.2% · price −1.4% | 1.8% | $6.81B | −$95.9M | ||||||||
| MastercardCL A · shares +3.8% · price +4.5% | 1.7% | $6.59B | +$273.9M | ||||||||
| Abbott LabsCOM · shares +6.4% · price −7.8% | 1.5% | $5.71B | −$453.2M | ||||||||
| Northrop Grumman CorpCOM · shares +2.0% · price −15.4% | 1.4% | $5.55B | −$988.5M | ||||||||
| Jpmorgan Chase & CoCOM · shares −3.9% · price −2.8% | 1.4% | $5.35B | −$155.9M | ||||||||
| General Electric CoCOM NEW · shares +125% · price +14.1% | 1.3% | $5.17B | +$284.1M | ||||||||
| Transdigm Group IncCOM · shares +0.1% · price +17.1% | 1.2% | $4.84B | +$704.4M | ||||||||
| Raytheon Technologies CorpCOM · shares −12% · price −3.0% | 1.2% | $4.51B | −$137.7M | ||||||||
| AmazonCOM · shares +0.5% · price +23.0% | 1.2% | $4.50B | +$836.1M | ||||||||
| NetflixCOM · shares −17% · price +17.2% | 1.1% | $4.29B | +$628.5M | ||||||||
| Bristol-Myers Squibb CoCOM · shares +17% · price −3.7% | 1.1% | $4.26B | −$139.6M | ||||||||
| AppleCOM · shares +4.3% · price +26.9% | 1.1% | $4.17B | +$847.3M | ||||||||
| Linde PlcSHS · shares New | 1.0% | $4.05B | — | ||||||||
| Visa Inc.COM CL A · shares +1.0% · price +8.5% | 0.97% | $3.78B | +$292.8M | ||||||||
| SempraCOM · shares +6.8% · price −2.2% | 0.96% | $3.72B | −$78.3M | ||||||||
| AlphabetCAP STK CL A · shares +19% · price +17.6% | 0.94% | $3.64B | +$457.2M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares +0.08% · price +0.6% | 0.87% | $3.40B | +$20.6M | ||||||||
| EquinixCOM · shares +5.2% · price +10.0% | 0.85% | $3.31B | +$285.8M | ||||||||
| Total · 437 positions | 100% | $388.71B | +$17.21B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 406 stocks held throughout, up $17.21B (+5.1%).
- Microsoft+$4.06B+20%
- Meta+$3.47B+76%
- Broadcom+$2.27B+15%
- Seagen Inc+$1.10B+58%
- Alphabet+$1.08B+17%
- Abbott Labs−$453.2M−8%
- Conocophillips−$463.0M−16%
- Pfizer Inc−$584.8M−20%
- Unitedhealth Group Inc−$853.1M−11%
- Northrop Grumman Corp−$988.5M−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |